Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the preliminary efficacy of finite therapy with the combination of GS-4059 and entospletinib with and without obinutuzumab in subjects with relapsed or refractory chronic lymphocytic leukemia (CLL)
Inclusion criteria
- Adults with relapsed or refractory chronic lymphocytic leukemia